Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

TAXES - Schedule of Deferred Income Tax Assets and Liabilities (Detail)

v3.22.1
TAXES - Schedule of Deferred Income Tax Assets and Liabilities (Detail) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Analysis of income and expense [abstract]    
Non-capital loss carryforwards $ 262,419 $ 236,883
Scientific Research Experimental Development ("SRED") credits 5,635 5,635
Share issuance cost 3,579 3,579
Excess carry value of capital assets over book 3,570 3,474
Total tax assets $ 275,203 $ 249,571